Cours Evotec SE Other OTC
Actions
EVTCY
US30050E1055
Recherche biotechnologique et médicale
CA 2024 * | 883 M 945 M 841 M | CA 2025 * | 1,04 Md 1,11 Md 988 M | Capitalisation | 1,49 Md 1,59 Md 1,42 Md |
---|---|---|---|---|---|
Résultat net 2024 * | -28 M -29,97 M -26,67 M | Résultat net 2025 * | 31 M 33,18 M 29,53 M | VE / CA 2024 * | 1,94 x |
Dette nette 2024 * | 227 M 243 M 216 M | Dette nette 2025 * | 186 M 200 M 178 M | VE / CA 2025 * | 1,61 x |
PER 2024 * |
-53,8
x | PER 2025 * |
31,7
x | Employés | - |
Rendement 2024 * |
-
| Rendement 2025 * |
-
| Flottant | 90,64% |
Dernier transcript sur Evotec SE
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Mario Polywka
CEO | Chief Executive Officer | 61 | 19/06/19 |
Laetitia Rouxel
DFI | Director of Finance/CFO | 51 | 07/02/23 |
Craig Johnstone
COO | Chief Operating Officer | 54 | 01/05/12 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Mario Polywka
CEO | Chief Executive Officer | 61 | 19/06/19 |
Roland Sackers
BRD | Director/Board Member | 56 | 19/06/19 |
Chairman | 63 | 17/06/14 |
Varia. 1 janv. | Capi. | |
---|---|---|
+40,80% | 53,67 Md | |
+35,79% | 38,86 Md | |
-8,05% | 38,76 Md | |
-8,98% | 27,27 Md | |
+10,69% | 25,91 Md | |
-16,21% | 20,29 Md | |
+31,00% | 12,78 Md | |
+28,51% | 12,18 Md | |
-1,67% | 11,96 Md |